Beyond the Blood Draw: Explainable Machine Learning for Non-Invasive Dysglycemia Risk Screening
arXiv:2606.16056v1 Announce Type: new Abstract: Dysglycemia, encompassing both prediabetes and diabetes, affects huge numbers of adults worldwide, yet many of them remain undiagnosed. We developed and validated machine-learning (ML) models for non-invasive screening of dysglycemia risk that require no laboratory tests. Pooling data from the National Health and Nutrition Examination Survey (NHANES) 2017--2023 (n=14,352), we trained six ML models with stratified 5-fold cross-validation and compared them with two established clinical risk scores. LightGBM achieved the highest area under the recei
The proliferation of machine learning capabilities and the availability of large health datasets like NHANES are enabling rapid advancements in non-invasive diagnostic methods.
This development represents a significant step towards more accessible and preventative healthcare, potentially reducing the burden of chronic diseases globally by facilitating early detection.
Traditional reliance on laboratory tests for dysglycemia screening can be augmented or potentially replaced by non-invasive, ML-driven methods, increasing screening rates and early intervention.
- · Healthcare technology companies
- · Patients at risk of dysglycemia
- · Public health systems
- · Traditional diagnostic lab services (for routine screening)
- · Companies offering only invasive screening solutions
Wider adoption of non-invasive ML tools for disease screening will lead to improved public health outcomes.
The reduced necessity for traditional clinical visits for initial screening could reshape healthcare delivery models, potentially increasing telemedicine reliance.
This success could accelerate the development and trust in ML-driven diagnostics across many other medical conditions, further decentralizing healthcare.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.LG